This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Nirmatrelvir-Ritonavir and COVID-19 mortality and hospitalization among patients with vulnerability to COVID-19 complications.
JAMA Network Open:2023: October 2 Full text
Clinical Practice
Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
Heart:2023: September 7 Full text
Commercial immunoglobulin products contain neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 spike protein.
Clinical Infectious Diseases:2023:77(7):950-60 Full text
Long COVID
Serotonin reduction in post-acute sequelae of viral infection.
Cell:2023: October 16 Full text
Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
BMC Public Health:2023: August 23 Full text
Swept under the carpet: a qualitative study of patient perspectives on Long COVID, treatments, services, and mental health.
BMC Health Services Research:2023: October 13 Full text
Experiences of people with long COVID: symptoms, support strategies and the Long COVID Optimal Health Programme (LC-OHP).
Health Expectations:2023: September 26 Full text
Autoimmune and autoinflammatory connective tissue disorders following COVID-19.
JAMA Network Open:2023: October 6 Full text
Infection Control
Generation of aerosols by noninvasive respiratory support modalities: a systematic review and meta-analysis.
JAMA Network Open:2023: October 11 Full text
Psychosocial Aspects
Educational impact of COVID-19 on foundation doctors and the decision to take a break from structured approved training programmes in the United Kingdom.
Clinical Teacher:2023: October 8 Full text
Cognitive behaviour therapy for pandemic-related anxiety and depression in adolescents: a pilot study of a novel intervention.
Australian Psychologist:2023: October 8 Full text
Vaccines
Variant-adapted COVID-19 booster vaccines.
Science:2023: October 12 Full text
Estimated effectiveness of a primary cycle of protein recombinant vaccine NVX-CoV2373 against COVID-19.
JAMA Network Open:2023: October 4 Full text
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
PNAS:2023: October 5 Full text
